Cite
Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: a multicenter, randomized, phase II trial.
MLA
Scagliotti, Giorgio V., et al. “Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non-Small Cell Lung Cancer: A Multicenter, Randomized, Phase II Trial.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 11, no. 2 Pt 1, Jan. 2005, pp. 690–96. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=15701857&authtype=sso&custid=ns315887.
APA
Scagliotti, G. V., Kortsik, C., Dark, G. G., Price, A., Manegold, C., Rosell, R., O’Brien, M., Peterson, P. M., Castellano, D., Selvaggi, G., Novello, S., Blatter, J., Kayitalire, L., Crino, L., & Paz-Ares, L. (2005). Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: a multicenter, randomized, phase II trial. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 11(2 Pt 1), 690–696.
Chicago
Scagliotti, Giorgio V, Cornelius Kortsik, Graham G Dark, Allan Price, Christian Manegold, Rafael Rosell, Mary O’Brien, et al. 2005. “Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non-Small Cell Lung Cancer: A Multicenter, Randomized, Phase II Trial.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 11 (2 Pt 1): 690–96. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=15701857&authtype=sso&custid=ns315887.